RNASEK and cancer: Our analysis of RNASEK expression across cancer stages revealed significant differences between stage 1 compared to stage 3 in ESCA, HNSC, and THCA, and significant differences were observed between stages 2 and 3 when compared to stage 4 in LIHC patients.